Direct oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation and CKD G3–G5D

BACKGROUND: The use of direct oral anticoagulants (DOAC) in patients with non-valvular atrial fibrillation (NVAF) and advanced chronic kidney disease (CKD) including dialysis is growing. Several studies have shown favorable results of DOAC compared with warfarin regarding bleeding risk but no differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Welander, Frida, Renlund, Henrik, Dimény, Emöke, Holmberg, Henrik, Själander, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157779/
https://www.ncbi.nlm.nih.gov/pubmed/37151425
http://dx.doi.org/10.1093/ckj/sfad004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157779/
https://www.ncbi.nlm.nih.gov/pubmed/37151425
http://dx.doi.org/10.1093/ckj/sfad004

Ejemplares similares